Research

Energy balance

GLP-1RAs have gastrointestinal side effects, particularly nausea, which limits their tolerability.

Clinicians should monitor for gastrointestinal side effects when prescribing GLP-1RAs.

StrongQualifiesmedium confidence
However, they have frequent gastrointestinal side effects, particularly nausea, which limits their tolerability.
Brian Tomlinson et al. · Expert Opinion on Investigational Drugs · 2016

Why this rating

The claim is based on expert opinion regarding side effects.

Source

Investigational glucagon-like peptide-1 agonists for the treatment of obesity

Brian Tomlinson et al. · Expert Opinion on Investigational Drugs · 2016

DOI 10.1080/13543784.2016.1221925

reviewCited 24×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →